🇺🇸 FDA
Patent

US 6498148

Immunization-free methods for treating antigen-stimulated inflammation in a mammalian host and shifting the host's antigen immune responsiveness to a Th1 phenotype

expired A61KA61K2039/53A61K2039/543

Quick answer

US patent 6498148 (Immunization-free methods for treating antigen-stimulated inflammation in a mammalian host and shifting the host's antigen immune responsiveness to a Th1 phenotype) held by The Regents of the University of California expires Mon Dec 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Dec 24 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K2039/53, A61K2039/543, A61K2039/55561, A61K39/35